Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -5 of 5 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Lucentis as an Adjuvanct Therapy With TTT-ICG Based in Choroidal Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 to 90				Other				FVF4290s NCT00680225


2.		Effect of Ranibizumab on Malignant Conjunctival Neoplasia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Active				21 and over				Other				4192s NCT00456495


3.		Effect of Intravitreal Ranibizumab on Radiation Retinopathy Following Plaque Brachytherapy for Choroidal Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Diagnostic, Supportive care				Active				21 and over				Other				FVF4519s NCT00750399


4.		Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Active				18 and over				Other, Pharmaceutical / Industry				FVF4384s MEEI Protocol #07-06-040, NCT00765921


5.		Ranibizumab for Neurofibromas Associated With Neurofibromatosis 1

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Treatment				Active				18 and over				Other				07-332 NCT00657202

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute